Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
Condition(s):Heart Failureļ¼CongestiveLast Updated:November 13, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Heart Failureļ¼CongestiveLast Updated:November 13, 2020Completed
Condition(s):Drug UseLast Updated:August 5, 2021Completed
Condition(s):Acute Renal Failure; Critical IllnessLast Updated:November 3, 2022Completed
Condition(s):Ovarian TorsionLast Updated:May 12, 2023Recruiting
Condition(s):Chronic Obstructive Pulmonary Disease Exacerbation; COPD ExacerbationLast Updated:March 15, 2023Not yet recruiting
Condition(s):Gastroretentive Drug Formulation of Furosemide; OedemaLast Updated:December 12, 2013Completed
Condition(s):Chronic Kidney DiseaseLast Updated:April 16, 2015Unknown status
Condition(s):Acute Heart FailureLast Updated:March 15, 2019Completed
Condition(s):Hypertension, Pregnancy-InducedLast Updated:December 1, 2022Terminated
Condition(s):Acute Kidney InjuryLast Updated:December 16, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.